Searched for
REDDY PHARMA NEWS
Reddy Pharma loses 'name' in Delhi HC rulingThe Delhi High Court has ruled against Reddy Pharmaceuticals. The court upheld a decision to remove 'Reddy' from the company's name. Reddy ...- Stocks in news: Groww, Dr Reddy's, Waaree Energies, Lenskart, SBIMarkets experienced a sharp risk-off session on Monday, with indices declining amid broad selling. Investors are advised to avoid aggressiv...
- Q4 earnings, crude oil, FII action among 8 factors to steer D-Street this weekIndian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Dr Reddy’s shares fall 2% after Goldman Sachs downgrades, Citi turns cautiousDr Reddy’s shares fell after Goldman Sachs and Citigroup turned cautious, citing limited growth visibility, pipeline concerns and valuation...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
- Stocks in news: Vedanta, Tata Capital, Tata Motors PV, Godrej Properties, Dr Reddy'sMarkets ended marginally higher after a volatile session, with analysts advising caution. Several companies like Vedanta, Tata Motors PV, a...
- Aurobindo Pharma plunges over 14% after ED arrests company director“The company learnt that P Sarath Chandra Reddy, whole-time director/ promoter group of the company, has been arrested by the Enforcement D...
- Pharma is in focus but there is no valuation comfort: Prabhudas Lilladher‘We have a buy on Dr Reddy’s and Lupin. Dr Reddy’s definitely has a positive but the valuation remains very challenging after this recent r...
- Licence to sell cancer drug biggest opportunity for Dr Reddy’s in US market: Nirmal Bang‘On a very conservative basis, the drug can add about $300 million to their sales in FY23-FY24.’
- Market Now: Sun Pharma, Cipla drag Nifty Pharma index downBharat Petroleum, Tata Motors, Sun Pharma and Hero MotoCorp were the top drags in the Nifty index.
- Market Now: Sun TV, Infosys among most active stocks in value termsPharma, realty and media indices surged over 2 per cent on NSE.
- Put trailing stop losses in place for midcap stocks: Guarang ShahWhen the lesser-known names start reacting on the negative side, then there would be a bit of deeper cut, says Shah in an interview with ET...
- Avoid Ranbaxy after USFDA revokes approval; prefer Dr. Reddy's from the pharma space: Mayuresh Joshi"Dr. Reddy’s has got and the valuation comfort that one drives with, Dr. Reddy’s becomes our preferred pick at this point of time."
- Short-term outlook positive for pharma stocks: JV Capital ServicesBuy with dips until the momentum is broken but for sure, short-term outlook is still reasonably positive for these stocks.
- Jaganmohan Reddy's arrest pulls down Ramky Infrastructure stock by 15 per centOn Monday, Ramky Infrastructure shares fell to a new 52-week low of 118.10 on news reports that the company may have made wrongful gains wh...
- Avoid Ranbaxy; bullish on Sun Pharma, Cipla: Ashwani GujralI would avoid Ranbaxy for the moment as it is too much news driven.
- Dr. Reddy Laboratories can get back to Rs 1,800-1,850: Ashwani GujralDr. Reddy is probably the strongest in the pharma lot. It has corrected towards Rs 1,470-1,480, and yesterday was a good day in Dr. Reddy.
- 'Pharma space looks exciting'Ashit Suri, Fundamental Research Analyst, JV Capital Services, spoke to ET Now on pharma stocks prospects. Excerpts:
Load More
